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Methods: Nested-PCR was used to amplify the HBV S gene and
the PCR products were sequenced directly or sequenced after
cloning, the sequences of ‘a’ epitope were then analyzed by
sequence alignment.
Results: Direct sequencing of PCR products showed that there
was one amino acid (AA) residue in ‘a’ epitope less conserved
region emerged polymorphism in each of all 4 HBV infected
patients with both positive HBsAg and HBsAb markers. Clone
sequencing showed that, the AA residue 126 of ‘a’ epitope in
patient 1 could be Thr, Ile and Ser, the AA residue 134 could be
Phe and Ser; the AA residue 126 in patient 2 could be Ala and
Thr, and patient 3 could be Ile and Asn; AA polymorphism was not
found in patient 4.
Conclusions: Mixture virus may exist in HBV infected patients
positive for HBsAg and HBsAb; the polymorphism of HBV quasi-
species ‘a’ epitope sequence should be one of the reasons caused
both HBsAg and HBsAb positive in HBV infected patients.
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Background: The Hepatitis viruses, a heterogenous group of
viruses with a tropism for the liver, are the major cause of viral
hepatitis. HBV and HCV are among the most important agents of
viral hepatitis. These viruses are spread parenterally by blood or
needles, by sexual contact and perinatally and etc.
Methods: 254 patients include 163 HBV and 91 HCV were studied
in this research. This study was carried out using recorded infor-
mation in ﬁle of patients in Tropical and Infectious Research Cen-
ter in Esfahan, and information was extracted from these ﬁles.
Results: The history of:
– surgery: HBV: 71 (28% of all patients) - HCV: 48 (18.9% of all
patients)
– blood transmission: HBV: 15 (6.1% of all patients) - HCV: 16
(6.2% of all patients)
– contact with hepatitis patient: HBV: 36 (14.2% of all patients)
- HCV: 15 (6.1% of all patients)
– accident: HBV: 23 (9% of all patients) - HCV: 20 (7.9% of all
patients)
– tattooing: HBV: 30 (11.8% of all patients) - HCV: 7 (2.75% of all
patients)
– cupping: HBV: 22 (8.66% of all patients) - HCV: 6 (2.4% of all
patients)
– sexual contact: HBV: 21 (8.3% of all patients) - HCV: 1 (0.39%
of all patients)
– renal dialysis: HBV and HCV: 0
Conclusion: It seems that the above mentioned risk factors are
very important in epidemiology of Hepatitis. Therefore efﬁcient
education to population and patients to control and prevention
of disease is necessary.
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Objectives: We aimed to characterize mutations of HBV genome
involving X gene, basal core promoter (BCP), and Precore/core
regions and also deﬁne HBV genotypes in patients of HCC from
India.
Methods: HBV genotypes and mutations were determined in 150
HCC and 136 chronic liver disease patients without HCC. All HBV
DNA positive cases were subjected to mutational analysis using
SSCP and genotyping by RFLP.
Results: Amongst 150 HCC patients, 79.4% and 20.6% had geno-
type D and A, respectively. The prevalence of genotype D was
signiﬁcantly higher in HCC patients compared with controls
(p=0.03). The T1484, TT1504, T1653, C1705, C1740, C/G1753,
T1762/A1764, A1896 and G1914 mutations were frequent in HCC
cases. The prevalence of the TT1504 mutation in the X gene,
the V1753 and T1762/A1764 mutations in BCP region and G1914
mutation in core gene were signiﬁcantly higher in the HCC group
compared to controls (48% vs 7%, 44% vs 7%, 70% vs 33% and 41%
vs 6.7%, respectively). Also, T1653 (58% vs 14%) mutation was
signiﬁcantly higher for HCC cases. Multivariate analyses showed
that the TT1504, 1653T, C1705, 1753V, and A1762T G1764A mu-
tations and patient age signiﬁcantly increased the risk of HCC
development. Also HCC had lower levels of serum albumin and
platelet count, but higher values of ALP, AST, ALT, Bilirubin and
AFP compared to controls (P<0.001).
Conclusion: HBV genotype D and the exclusively found preva-
lence of certain mutations detected in those with HBV-related
carcinoma nevertheless indicate a degree of association with
disease progression in Indian patients.
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Objective: To study the prevalence of resolved hepatitis B virus
(HBV) infection in patients with primary biliary cirrhosis (PBC)
and whether the resolved infection is associated with much poor
prognosis.
Methods: Sixty PBC patients with negative serum HBsAg were
further measured for other serum HBV infection markers, in-
cluding anti-HBs, HBeAg, HBeAb, HBcAb and HBV DNA. Patients
with resolved HBV infection were termed as serum HBcAb pos-
itive (±anti-HBs±HBeAb), HBsAg negative and HBV DNA unde-
tectable. The severity of the disease including the occurrence
of hypoalbuminemia and/or jaundice, complications of decom-
pensated cirrhosis/portal hypertension such as ascites, hepatic
encephalopathy, upper gastrointestinal variceal bleeding or the
occurrence of hepatocellular carcinoma was compared between
patients with and without resolved HBV infection.
Results: There were 25 patients (41.7%, 58.9±11.3 yr) with
resolved HBV infection and 35 patients (58.3%, 57.8±11.5 yr)
without resolved HBV infection. Complications of decompen-
sated cirrhosis/portal hypertension or the occurrence of HCC
were more frequently occurred in PBC patients with resolved
HBV infection than patients without resolved HBV infection (72%
vs. 37.14%, P<0.01).
Conclusion: Resolved HBV infection was common in Chinese PBC
patients and may be related with much poor prognosis.
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Background: We found a new point mutation A to T in the HBsAg
